Artelo Biosciences Inc

NASDAQ:ARTL   9:47:16 AM EDT
0.56
0.00 (-0.74%)
Products, Regulatory, Other Pre-Announcement

Artelo Biosciences Announces Clinical Trial Authorization To Commence Cancer Appetite Recovery Study For The Treatment Of Cancer-Related Anorexia, Weight Loss

Published: 11/16/2020 13:43 GMT
ARTELO BIOSCIENCES, INC. (ARTL) - Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-related Anorexia and Weight Loss.
Artelo Biosciences Inc - Announced Receipt of Clinical Trial Authorization in Uk for Co's Cancer Appetite Recovery Study.
Artelo Biosciences Inc - Expects Study to Initiate Enrollment Before Year End.